Coronavirus vaccine: Germany approves first human trials

A clinical test of a COVID-19 vaccine in Germany has been approved, the country’s Federal Institute for Vaccines has said.

According to the independent nThis will see 200 healthy people between the age of 18 and 55 receive several variants of the vaccine as scientists examine its efficacy in providing immunity against the deadly virus.

The race is on to develop a vaccine which will be able to help contain the spread of coronavirus, which has so far killed more than 177,000 people and infected 2.5 million, according to figures from Johns Hopkins University.

The World Health Organisation (WHO) says that there are at least 20 different COVID-19 vaccines currently in development, including a handful at the clinical trial stage

What's happening in Tunisia?
Subscribe to our Youtube channel for updates.

Top 48h

Copyright © 2019 Tunisie Numerique

To Top